aloxi Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aloxi, and when can generic versions of Aloxi launch?
Aloxi is a drug marketed by Helsinn Hlthcare and is included in two NDAs. There are thirteen patents protecting this drug and one Paragraph IV challenge.
This drug has fifty-three patent family members in forty countries.
The generic ingredient in ALOXI is palonosetron hydrochloride. There are twenty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the palonosetron hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aloxi
A generic version of aloxi was approved as palonosetron hydrochloride by SANDOZ on October 13th, 2015.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for aloxi?
- What are the global sales for aloxi?
- What is Average Wholesale Price for aloxi?
Summary for aloxi
International Patents: | 53 |
US Patents: | 13 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 156 |
Patent Applications: | 3,953 |
Drug Prices: | Drug price information for aloxi |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for aloxi |
What excipients (inactive ingredients) are in aloxi? | aloxi excipients list |
DailyMed Link: | aloxi at DailyMed |
Paragraph IV (Patent) Challenges for ALOXI
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
ALOXI | Injection | palonosetron hydrochloride | 0.05 mg/mL, 1.5 mL and 5 mL vials | 021372 | 3 | 2011-05-27 |
US Patents and Regulatory Information for aloxi
aloxi is protected by seven US patents.
Patents protecting aloxi
Liquid pharmaceutical formulations of palonosetron
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Liquid pharmaceutical formulations of palonosetron
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Liquid pharmaceutical formulations of palonosetron
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Liquid pharmaceutical formulations of palonosetron
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Liquid pharmaceutical formulations of palonosetron
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Liquid pharmaceutical formulations of palonosetron
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Liquid pharmaceutical formulations of palonosetron
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | CAPSULE;ORAL | 022233-001 | Aug 22, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for aloxi
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | ⤷ Sign Up | ⤷ Sign Up |
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for aloxi
See the table below for patents covering aloxi around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Netherlands | 300194 | ⤷ Sign Up | |
Eurasian Patent Organization | 200501203 | ЖИДКИЕ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ ПАЛОНОСЕТРОНА | ⤷ Sign Up |
Canada | 2514224 | FORMULATIONS PHARMACEUTIQUES LIQUIDES DE PALONOSETRONE (LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON) | ⤷ Sign Up |
Uruguay | 28175 | FORMULACIONES FARMACEUTICAS LIQUIDAS DE PALONOSETRON | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for aloxi
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2785706 | C02785706/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: FOSNETUPITANT, PALONOSETRON.; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 68290 01.09.2022 |
2785706 | 122020000046 | Germany | ⤷ Sign Up | PRODUCT NAME: FOSNETUPITANT MIT PALONOSETRON; REGISTRATION NO/DATE: C(2020)1804(FINAL) 20200316 |
2785706 | 2020C/516 | Belgium | ⤷ Sign Up | PRODUCT NAME: AKYNZEO - FOSNETUPITANT/PALONOSETRON; AUTHORISATION NUMBER AND DATE: EU/1/15/1001 20200318 |
0430190 | CA 2005 00023 | Denmark | ⤷ Sign Up | |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |